📰 Alacyclovir News
Page 2 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
November 15, 2023
Flu is still nothing to mess with, and officials are promoting the flu activity results as a reminder for people to get their flu shots as soon as possible.
November 13, 2023
Though antivirals are critical for reducing severe COVID-19 symptoms, researchers suggested that the medication may not always be needed for milder cases.
October 31, 2023
With the exception of venous thromboembolism and pulmonary embolism events, the antiviral drug did not reduce the incidence of post-COVID-19 conditions in a study of nearly 10,000 US veterans.
October 19, 2023
Pfizer on Wednesday said it will set the US price for its COVID-19 antiviral treatment Paxlovid at nearly $1400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it.
October 5, 2023
The government will stop distributing free doses of Mercks COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.
October 4, 2023
The combination of pleconaril and ribavirin prolonged endogenous insulin production in children and teens with new-onset type 1 diabetes.
September 29, 2023
Drawbacks to fully ablative laser resurfacing include significant downtime and extensive wound care, "so it’s not for everybody," says Arisa E. Ortiz, MD.
September 27, 2023
Alcohol use at any level was not associated with a lower likelihood of responding to direct-acting antiviral therapy for chronic hepatitis C virus infection.
September 27, 2023
Pfizers chief executive said on Tuesday that almost 250,000 courses of the drugmakers oral antiviral COVID-19 treatment Paxlovid were being administered per week.
September 26, 2023
Researchers looked at 15 million COVID genomes and discovered that hallmark mutations linked to molnupiravir increased in 2022.